COO Financials: Cooper Companies Inc AI Analysis



Financials

COO Financial

Cooper Companies Inc

$67.34

8.57%

$5.32

At close: Jun 05, 16:00:00 GMT-4

$67.08

-0.38%

$-0.26

Pre-market: Jun 08, 06:24:20 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$62.02

Open

$65.1

Day's Range

$65 - $67.61

52 week range

$58.89 - $89.83

Volume

9.0M

Avg.Volume

2.2M

Dividend yield

0.00%

EPS (TTM)

2.20

Market Cap

$13.0B

What is COO?

The Cooper Cos, Inc. operates as a medical device company. The company is headquartered in San Ramon, California and currently employs 16,000 full-time employees. The firm operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage), and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. The company also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.

Markets

News

Breakdown	TTM	01/31/2026	10/31/2025	07/31/2025	04/30/2025	01/31/2025
Revenue	4,151	1,024	1,065	1,060	1,002	964
Revenue Growth (YoY)	6%	6%	5%	6%	6%	4%
Cost of Revenue	1,434	328	414	368	323	304
Gross Profit	2,717	695	650	692	679	660
Selling, General & Admin	1,630	390	419	421	399	387
Research & Development	175	44	41	44	45	40
Operating Expenses	2,003	482	510	516	494	478
Other Non Operating Income (Expenses)	-5	3	3	3	-14	0
Pretax Income	605	192	116	151	144	153
Income Tax Expense	204	61	32	53	56	49
Net Income	401	130	84	98	87	104
Net Income Growth	-3%	25%	-28%	-6%	-1%	28%
Shares Outstanding (Diluted)	196.7	196.7	198.2	200	200.7	201.2
Shares Change (YoY)	-2%	-2%	-1%	0%	0%	1%
EPS (Diluted)	2.04	0.66	0.42	0.49	0.43	0.51
EPS Growth	-1%	28%	-28%	-5%	-1%	26%
Free Cash Flow	491	158	149	164	18	101
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	65.45%	67.87%	61.03%	65.28%	67.76%	68.46%
Operating Margin	17.17%	20.7%	13.14%	16.5%	18.36%	18.87%
Profit Margin	9.66%	12.69%	7.88%	9.24%	8.68%	10.78%
Free Cash Flow Margin	11.82%	15.42%	13.99%	15.47%	1.79%	10.47%
EBITDA	1,094	307	238	270	276	273
EBITDA Margin	26.35%	29.98%	22.34%	25.47%	27.54%	28.31%
D&A For EBITDA	381	95	98	95	92	91
EBIT	713	212	140	175	184	182
EBIT Margin	17.17%	20.7%	13.14%	16.5%	18.36%	18.87%
Effective Tax Rate	33.71%	31.77%	27.58%	35.09%	38.88%	32.02%

Breakdown

TTM

01/31/2026

10/31/2025

07/31/2025

04/30/2025

01/31/2025

Revenue

4,151

1,024

1,065

1,060

1,002

964

Revenue Growth (YoY)

Cost of Revenue

1,434

328

414

368

323

304

Gross Profit

2,717

695

650

692

679

660

Selling, General & Admin

1,630

390

419

421

399

387

Research & Development

175

Operating Expenses

2,003

482

510

516

494

478

Other Non Operating Income (Expenses)

-5

-14

Pretax Income

605

192

116

151

144

153

Income Tax Expense

204

Net Income

401

130

104

Net Income Growth

-3%

25%

-28%

-6%

-1%

28%

Shares Outstanding (Diluted)

196.7

198.2

200

200.7

201.2

Shares Change (YoY)

-2%

-1%

EPS (Diluted)

2.04

0.66

0.42

0.49

0.43

0.51

EPS Growth

-1%

28%

-28%

-5%

-1%

26%

Free Cash Flow

491

158

149

164

101

Free Cash Flow Per Share

Gross Margin

65.45%

67.87%

61.03%

65.28%

67.76%

68.46%

Operating Margin

17.17%

20.7%

13.14%

16.5%

18.36%

18.87%

Profit Margin

9.66%

12.69%

7.88%

9.24%

8.68%

10.78%

Free Cash Flow Margin

11.82%

15.42%

13.99%

15.47%

1.79%

10.47%

EBITDA

1,094

307

238

270

276

273

EBITDA Margin

26.35%

29.98%

22.34%

25.47%

27.54%

28.31%

D&A For EBITDA

381

EBIT

713

212

140

175

184

182

EBIT Margin

17.17%

20.7%

13.14%

16.5%

18.36%

18.87%

Effective Tax Rate

33.71%

31.77%

27.58%

35.09%

38.88%

32.02%

Follow-Up Questions

What are Cooper Companies Inc's key financial statements?



According to the latest financial statement (Form-10K), Cooper Companies Inc has a total asset of $0, Net loss of $0

What are the key financial ratios for COO?



Cooper Companies Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Cooper Companies Inc's revenue broken down by segment or geography?



Cooper Companies Inc largest revenue segment is Other, at a revenue of -24,000 in the most earnings release.For geography, United States is the primary market for Cooper Companies Inc, at a revenue of 2,054,000,000.

Is Cooper Companies Inc profitable?



no, according to the latest financial statements, Cooper Companies Inc has a net loss of $0

Does Cooper Companies Inc have any liabilities?



no, Cooper Companies Inc has liability of 0

How many outstanding shares for Cooper Companies Inc?



Cooper Companies Inc has a total outstanding shares of 0

Cooper Companies Inc (COO) Financial

COO Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is COO?

Cooper Companies Inc (COO) Financial

COO Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is COO?

COO Income

Follow-Up Questions

What are Cooper Companies Inc's key financial statements?

What are the key financial ratios for COO?

How is Cooper Companies Inc's revenue broken down by segment or geography?

Is Cooper Companies Inc profitable?

Does Cooper Companies Inc have any liabilities?

How many outstanding shares for Cooper Companies Inc?